Tolazamide is a first-generation sulfonylurea antidiabetic agent used in the management of type 2 diabetes, primarily by stimulating insulin secretion from pancreatic beta cells to regulate blood glucose… Read more








Tolazamide is a first-generation sulfonylurea antidiabetic agent used in the management of type 2 diabetes, primarily by stimulating insulin secretion from pancreatic beta cells to regulate blood glucose levels. This category includes high-quality reference standards for the active pharmaceutical ingredient, as well as a comprehensive selection of related compounds necessary for rigorous pharmaceutical analysis. Laboratories rely on these materials, including pharmacopeial and non-pharmacopeial impurities, to perform precise impurity profiling and method validation throughout the drug development and manufacturing lifecycle. Additionally, stable isotope labelled compounds such as Tolazamide-d7 are essential for use as internal standards in mass spectrometry-based assays, ensuring accurate quantification and reliable quality control. By providing these critical chemical standards, researchers can maintain compliance with regulatory guidelines and ensure the integrity of analytical testing for this sulfonylurea therapeutic.